Patent · US Active

Inhibitors of RET

US10030005B2 · kind B2 · utility

28Cited by
12References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 1, 2016
Grant dateJul 24, 2018
Priority date
Expiry dateNov 1, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.